
{
    "credit": [
        {
            "email": "han@cdfd.org.in",
            "name": "H.A.Nagarajaram",
            "typeEntity": "Person",
            "typeRoles": [
                "Primary contact"
            ],
            "url": "http://www.cdfd.org.in/labpages/computational_biology_group.html"
        }
    ],
    "documentation": [
        {
            "type": "GENERAL",
            "url": "http://hansa.cdfd.org.in:8080/index.php?target=method"
        }
    ],
    "function": [
        {
            "operation": [
                {
                    "term": "Prediction and recognition",
                    "uri": "http://edamontology.org/operation_2423"
                },
                {
                    "term": "Protein sequence analysis",
                    "uri": "http://edamontology.org/operation_2479"
                },
                {
                    "term": "Genetic variation analysis",
                    "uri": "http://edamontology.org/operation_3197"
                }
            ]
        }
    ],
    "labels": {
        "operatingSystem": [
            "Linux",
            "Windows",
            "Mac"
        ],
        "toolType": [
            "Web application"
        ],
        "topic": [
            {
                "term": "DNA mutation",
                "uri": "http://edamontology.org/topic_2533"
            },
            {
                "term": "Pathology",
                "uri": "http://edamontology.org/topic_0634"
            },
            {
                "term": "Genetics",
                "uri": "http://edamontology.org/topic_3053"
            }
        ]
    },
    "link": [
        {
            "type": "SOFTWARE_CATALOGUE",
            "url": "http://www.mybiosoftware.com/hansa-discriminating-disease-and-neutral-human-nssnps.html"
        }
    ],
    "publication": [
        {
            "abstract": "Variations are mostly due to nonsynonymous single nucleotide polymorphisms (nsSNPs), some of which are associated with certain diseases. Phenotypic effects of a large number of nsSNPs have not been characterized. Although several methods have been developed to predict the effects of nsSNPs as \"disease\" or \"neutral,\" there is still a need for development of methods with improved prediction accuracies. We, therefore, developed a support vector machine (SVM) based method named Hansa which uses a novel set of discriminatory features to classify nsSNPs into disease (pathogenic) and benign (neutral) types. Validation studies on a benchmark dataset and further on an independent dataset of wellcharacterized known disease and neutral mutations show that Hansa outperforms the other known methods. For example, fivefold cross-validation studies using the benchmark HumVar dataset reveal that at the false positive rate (FPR) of 20% Hansa yields a true positive rate (TPR) of 82% that is about 10% higher than the best-known method. Â© 2011 Wiley Periodicals, Inc.",
            "authors": [
                "Acharya V.",
                "Nagarajaram H.A."
            ],
            "cit_count": 37,
            "journal": "Human Mutation",
            "pmid": "22045683",
            "title": "Hansa: An automated method for discriminating disease and neutral human nsSNPs",
            "year": "2012-02-01"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:hansa",
        "biotoolsID": "hansa",
        "description": "Tool to predict the deleterious effects of a mutation by using 10 Neutral- Disease Mis-Sense Mutation Discriminatory (NDMSMD) features.",
        "homepage": "http://hansa.cdfd.org.in:8080/",
        "name": "Hansa"
    }
}